<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36448241</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2328-9503</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Annals of clinical and translational neurology</Title><ISOAbbreviation>Ann Clin Transl Neurol</ISOAbbreviation></Journal><ArticleTitle>Well-being on supportive techniques in amyotrophic lateral sclerosis: from neurologists' perspective.</ArticleTitle><Pagination><StartPage>1874</StartPage><EndPage>1883</EndPage><MedlinePgn>1874-1883</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acn3.51663</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate intercultural neurologists' perception of well-being in patients with amyotrophic lateral sclerosis (ALS) using gastrostomy (PEG), non-invasive, and/or invasive ventilation (NIV/IV) and to analyse the determinants and impact on the management of the above medical interventions (MIs).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study was based on anonymous questionnaires addressing the clinical approach and personal attitude towards the use of PEG, NIV and IV in ALS patients completed by 465 neurologists: 228 from Germany and 237 from Poland.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The German and Polish neurologists estimated the quality of life in ALS patients using PEG and NIV as neutral, whilst low in individuals using IV. A regression model revealed an independent influence of palliative care training (PCT) and age on that attitude in the German group. Higher values of estimated patients' depressiveness on PEG, NIV and IV were found amongst the Polish neurologists. Marital status, experience in ALS and being a parent independently influenced the perception of patients' depressiveness in the German, whilst marital status, age and PCT were factors in the Polish group. Amongst German neurologists, a higher perception of patients' depressiveness in individuals using PEG, NIV and IV was linked to the later timing of the MIs discussion. In the Polish group, it was a lower estimation of QoL in patients using PEG.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Neurologists' perception of ALS patients' well-being on MIs reflects their demographic status, professional experience and potentially their cultural background. This perception plays an important role in the timing of MIs discussion, possibly influencing the decision-making process.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bar&#x107;</LastName><ForeName>Krzysztof</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-9668-6446</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University Clinical Centre of Medical University of Warsaw, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lul&#xe9;</LastName><ForeName>Doroth&#xe9;e</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-5944-398X</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finsel</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helczyk</LastName><ForeName>Olga</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baader</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aho-&#xd6;zhan</LastName><ForeName>Helena</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludolph</LastName><ForeName>Albert C</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0002-5401-0904</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Ulm, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center of Neurodegenerative Diseases (DZNE), Ulm site, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ku&#x17a;ma-Kozakiewicz</LastName><ForeName>Magdalena</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-9676-1263</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Warsaw, Warsaw, Poland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurodegenerative Diseases Research Group, Medical University of Warsaw, Warsaw, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>O1GI1007A</GrantID><Agency>FTLDc</Agency><Country/></Grant><Grant><GrantID>01GM1103A</GrantID><Agency>MND-Net</Agency><Country/></Grant><Grant><GrantID>01ED1405</GrantID><Agency>NEEDSinALS</Agency><Country/></Grant><Grant><GrantID>01DS18031</GrantID><Agency>PaCeMed</Agency><Country/></Grant><Grant><GrantID>3/IV/MAXOMOD/11/2020</GrantID><Agency>ERA-NET-E-Rare</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Clin Transl Neurol</MedlineTA><NlmUniqueID>101623278</NlmUniqueID><ISSNLinking>2328-9503</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072141" MajorTopicYN="N">Neurologists</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005774" MajorTopicYN="N">Gastrostomy</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>None to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>30</Day><Hour>2</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36448241</ArticleId><ArticleId IdType="pmc">PMC9735360</ArticleId><ArticleId IdType="doi">10.1002/acn3.51663</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McCluskey G, Duddy W, Haffey S, Morrison K, Donaghy C, Duguez S. Epidemiology and survival trends of motor neurone disease in Northern Ireland from 2015 to 2019. Eur J Neurol. 2022;29:707&#x2010;714.</Citation><ArticleIdList><ArticleId IdType="pubmed">34748676</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27:1918&#x2010;1929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannaford A, Pavey N, van den Bos M, et&#xa0;al. Diagnostic utility of gold coast criteria in amyotrophic lateral sclerosis. Ann Neurol. 2021;89:979&#x2010;986.</Citation><ArticleIdList><ArticleId IdType="pubmed">33565111</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahlqvist JR, Widholm P, Leinhard OD, Vissing J. MRI in neuromuscular diseases: an emerging diagnostic tool and biomarker for prognosis and efficacy. Ann Neurol. 2020;88:669&#x2010;681.</Citation><ArticleIdList><ArticleId IdType="pubmed">32495452</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Blanc G, Jett&#xe9; Pomerleau V, McCarthy J, et&#xa0;al. Faster cortical thinning and surface area loss in presymptomatic and symptomatic C9orf72 repeat expansion adult carriers. Ann Neurol. 2020;88:113&#x2010;122.</Citation><ArticleIdList><ArticleId IdType="pubmed">32285980</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandres&#x2010;Ciga S, Noyce AJ, Hemani G, et&#xa0;al. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. Ann Neurol. 2019;85:470&#x2010;481. Epub 2019 Mar 13. Erratum in: Ann Neurol 2020 Jun;87(6):991&#x2013;992.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6450729</ArticleId><ArticleId IdType="pubmed">30723964</ArticleId></ArticleIdList></Reference><Reference><Citation>Bar&#x107; K, Ku&#x17a;ma&#x2010;Kozakiewicz M. Gastrostomy and mechanical ventilation in amyotrophic lateral sclerosis: how best to support the decision&#x2010;making process? Neurol Neurochir pol. 2020;54:366&#x2010;377.</Citation><ArticleIdList><ArticleId IdType="pubmed">33058114</ArticleId></ArticleIdList></Reference><Reference><Citation>Spittel S, Maier A, Kettemann D, et&#xa0;al. Non&#x2010;invasive and tracheostomy invasive ventilation in amyotrophic lateral sclerosis: utilization and survival rates in a cohort study over 12&#x2009;years in Germany. Eur J Neurol. 2021;28:1160&#x2010;1171.</Citation><ArticleIdList><ArticleId IdType="pubmed">33210770</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler FJ Jr, Coppola KM, Teno JM. Methodological challenges for measuring quality of care at the end of life. J Pain Symptom Manage. 1999;17:114&#x2010;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">10069151</ArticleId></ArticleIdList></Reference><Reference><Citation>Vig EK, Pearlman RA. Good and bad dying from the perspective of terminally ill men. Arch Intern Med. 2004;164:977&#x2010;981.</Citation><ArticleIdList><ArticleId IdType="pubmed">15136306</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierson CM, Curtis JR, Patrick DL. A good death: a qualitative study of patients with advanced AIDS. AIDS Care. 2002;14:587&#x2010;598.</Citation><ArticleIdList><ArticleId IdType="pubmed">12419108</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeber AA, Hijdra A, Vermeulen M, Willems DL. Discussions about treatment restrictions in chronic neurologic diseases: a structured review. Neurology. 2012;78:590&#x2010;597.</Citation><ArticleIdList><ArticleId IdType="pubmed">22351797</ArticleId></ArticleIdList></Reference><Reference><Citation>Munroe CA, Sirdofsky MD, Kuru T, Anderson ED. End&#x2010;of&#x2010;life decision making in 42 patients with amyotrophic lateral sclerosis. Respir Care. 2007;52:996&#x2010;999.</Citation><ArticleIdList><ArticleId IdType="pubmed">17650354</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss AH, Casey P, Stocking CB, Roos RP, Brooks BR, Siegler M. Home ventilation for amyotrophic lateral sclerosis patients: outcomes, costs, and patient, family, and physician attitudes. Neurology. 1993;43:438&#x2010;443.</Citation><ArticleIdList><ArticleId IdType="pubmed">8437718</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabkin J, Ogino M, Goetz R, et&#xa0;al. Tracheostomy with invasive ventilation for ALS patients: neurologists' roles in the US and Japan. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:116&#x2010;123.</Citation><ArticleIdList><ArticleId IdType="pubmed">23039060</ArticleId></ArticleIdList></Reference><Reference><Citation>Aho&#x2010;&#xd6;zhan HE, B&#xf6;hm S, Keller J, et&#xa0;al. Experience matters: neurologists' perspectives on ALS patients' well&#x2010;being. J Neurol. 2017;264:639&#x2010;646.</Citation><ArticleIdList><ArticleId IdType="pubmed">28120043</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Beek K, Woitha K, Ahmed N, et&#xa0;al. Comparison of legislation, regulations and national health strategies for palliative care in seven European countries (results from the Europall research group): a descriptive study. BMC Health Serv Res. 2013;13:275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3720186</ArticleId><ArticleId IdType="pubmed">23866928</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawlowski L, Modli&#x144;ska A, Lichodziejewska&#x2010;Niemierko M. Selected aspects of advance care planning according to polish legal regulations&#x2014;physician's requirements. Palliat Med Pract. 2019;13:197&#x2010;203.</Citation></Reference><Reference><Citation>Wiesing U, Jox RJ, Hessler HJ, Borasio GD. A new law on advance directives in Germany. J Med Ethics. 2010;36:779&#x2010;783.</Citation><ArticleIdList><ArticleId IdType="pubmed">21112938</ArticleId></ArticleIdList></Reference><Reference><Citation>Grehl T, Rupp M, Budde P, Tegenthoff M, Fangerau H. Depression and QOL in patients with ALS: how do self&#x2010;ratings and ratings by relatives differ? Qual Life Res. 2011;20:569&#x2010;574.</Citation><ArticleIdList><ArticleId IdType="pubmed">21086185</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuzma&#x2010;Kozakiewicz M, Andersen PM, Ciecwierska K, et&#xa0;al. An observational study on quality of life and preferences to sustain life in locked&#x2010;in state. Neurology. 2019;93:e938&#x2010;e945.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6745736</ArticleId><ArticleId IdType="pubmed">31391247</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Kuzma&#x2010;Kozakiewicz M, Keller J, et&#xa0;al. Therapeutic decisions in ALS patients: cross&#x2010;cultural differences and clinical implications. J Neurol. 2018;265:1600&#x2010;1606.</Citation><ArticleIdList><ArticleId IdType="pubmed">29728768</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Ku&#x17a;ma&#x2010;Kozakiewicz M, Keller J, et&#xa0;al. Caregivers' divergent perspectives on patients' well&#x2010;being and attitudes towards hastened death in Germany, Poland and Sweden. Amyotroph Lateral Scler Frontotemporal Degener. 2022;23(3&#x2013;4):252&#x2010;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">34187249</ArticleId></ArticleIdList></Reference><Reference><Citation>Trail M, Nelson ND, Van JN, et&#xa0;al. A study comparing patients with amyotrophic lateral sclerosis and their caregivers on measures of quality of life, depression, and their attitudes toward treatment options. J Neurol Sci. 2008;209(1&#x2013;2):79&#x2010;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">12686407</ArticleId></ArticleIdList></Reference><Reference><Citation>Bremer BA, Simone AL, Walsh S, Simmons Z, Felgoise SH. Factors supporting quality of life over time for individuals with amyotrophic lateral sclerosis: the role of positive self&#x2010;perception and religiosity. Ann Behav Med. 2004;28:119&#x2010;125.</Citation><ArticleIdList><ArticleId IdType="pubmed">15454359</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabkin JG, Albert SM, Del Bene ML, et&#xa0;al. Prevalence of depressive disorders and change over time in late&#x2010;stage ALS. Neurology. 2005;65:62&#x2010;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1201558</ArticleId><ArticleId IdType="pubmed">16009886</ArticleId></ArticleIdList></Reference><Reference><Citation>Lule D, Micheel S, Finsel J, et&#xa0;al. Clinicoanatomical substrates of selfish behaviour in amyotrophic lateral sclerosis&#x2014;an observational cohort study. Cortex. 2022;146:261&#x2010;270.</Citation><ArticleIdList><ArticleId IdType="pubmed">34923303</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D, Ehlich B, Lang D, et&#xa0;al. Quality of life in fatal disease: the flawed judgement of the social environment. J Neurol 2013;260:2836&#x2013;43. Epub 2013 Aug 30. PMID: 23989341.</Citation><ArticleIdList><ArticleId IdType="pubmed">23989341</ArticleId></ArticleIdList></Reference><Reference><Citation>Linse K, R&#xfc;ger W, Joos M, Schmitz&#x2010;Peiffer H, Storch A, Hermann A. Eye&#x2010;tracking&#x2010;based assessment suggests preserved well&#x2010;being in locked&#x2010;in patients. Ann Neurol. 2017;81:310&#x2010;315. PMID: 28074605.</Citation><ArticleIdList><ArticleId IdType="pubmed">28074605</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelot&#x2010;Panzini C, Bruneteau G, Gonzalez&#x2010;Bermejo J. NIV in amyotrophic lateral sclerosis: the &#x2018;when&#x2019; and &#x2018;how&#x2019; of the matter. Respirology. 2019;24:521&#x2010;530.</Citation><ArticleIdList><ArticleId IdType="pubmed">30912216</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemoignan J, Ells C. Amyotrophic lateral sclerosis and assisted ventilation: how patients decide. Palliat Support Care. 2010;8:207&#x2010;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">20557668</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin NH, Lawrence V, Murray J, et&#xa0;al. Decision making about gastrostomy and noninvasive ventilation in amyotrophic lateral sclerosis. Qual Health Res. 2016;26:1366&#x2010;1381.</Citation><ArticleIdList><ArticleId IdType="pubmed">25918114</ArticleId></ArticleIdList></Reference><Reference><Citation>Young JM, Marshall CL, Anderson EJ. Amyotrophic lateral sclerosis patients' perspectives on use of mechanical ventilation. Health Soc Work. 1994;19:253&#x2010;260.</Citation><ArticleIdList><ArticleId IdType="pubmed">7813963</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeber AA, Pols AJ, Hijdra A, Grupstra HF, Willems DL, de Visser M. Advance care planning in progressive neurological diseases: lessons from ALS. BMC Palliat Care. 2019;18:50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6567602</ArticleId><ArticleId IdType="pubmed">31196046</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaub&#x2010;Wittemer D, von Steinb&#xfc;chel N, Wasner M, et&#xa0;al. Quality of life and psychosocial issues in ventilated patients with amyotrophic lateral sclerosis and their caregivers. J Pain Symptom Manage. 2003;26:890&#x2010;896.</Citation><ArticleIdList><ArticleId IdType="pubmed">14527757</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverstein MD, Stocking CB, Antel JP, Beckwith J, Roos RP, Siegler M. Amyotrophic lateral sclerosis and life&#x2010;sustaining therapy: patients' desires for information, participation in decision making, and life&#x2010;sustaining therapy. Mayo Clin Proc. 1991;66:906&#x2010;913.</Citation><ArticleIdList><ArticleId IdType="pubmed">1921500</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruffell TO, Martin NH, Janssen A, et&#xa0;al. Healthcare professionals' views on the provision of gastrostomy and noninvasive ventilation to amyotrophic lateral sclerosis patients in England, Wales, and Northern Ireland. J Palliat Care. 2013;29:225&#x2010;231.</Citation><ArticleIdList><ArticleId IdType="pubmed">24601073</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhlmann RF, Pearlman RA. Perceived quality of life and preferences for life&#x2010;sustaining treatment in older adults. Arch Intern Med. 1991;151:495&#x2010;497.</Citation><ArticleIdList><ArticleId IdType="pubmed">2001131</ArticleId></ArticleIdList></Reference><Reference><Citation>Demez PH, Moreau PR. The generalists' perception of quality of life in head and neck cancer. B&#x2010;Ent. 2015;11:163&#x2010;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">26601548</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulmasy DP, Hughes MT, Thompson RE, et&#xa0;al. How would terminally ill patients have others make decisions for them in the event of decisional incapacity? A longitudinal study. J Am Geriatr Soc. 2007;55:1981&#x2010;1988.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2583169</ArticleId><ArticleId IdType="pubmed">18031490</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan MT, Hughes M, Narendra DP, et&#xa0;al. When patients lack capacity: the roles that patients with terminal diagnoses would choose for their physicians and loved ones in making medical decisions. J Pain Symptom Manage. 2005;30:342&#x2010;353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2604910</ArticleId><ArticleId IdType="pubmed">16256898</ArticleId></ArticleIdList></Reference><Reference><Citation>Svensson M, Svensson T, Hansen AW, Trolle Lagerros Y. The effect of reminders in a web&#x2010;based intervention study. Eur J Epidemiol. 2012;27:333&#x2010;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">22531973</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>